Skip to main navigation Skip to search Skip to main content

Pharmacokinetic and toxicity studies of EquBind: a specific and potent molecule to treat Transthyretin Amyloidosis

Project Details

AcronymEquBind
StatusFinished
Effective start/end date1/06/19 → 30/11/21